Pharmaceutics
Pharmacogenomics of CYP2D6, CYP2C19, CYP2C9, and Clinical Determinants of Fluoxetine-Norfluoxetine Pharmacokinetics in Real-World Clinical Conditions.
Carla González de la Cruz, Levin Thomas, Carmen Mata-Martín, Idian González, Adrián LLerena, Eva M Peñas-Lledó
Published: 202510.3390/pharmaceutics18010041
Abstract
Background: Fluoxetine, a widely prescribed selective serotonin reuptake inhibitor, exhibits significant interindividual variability in pharmacokinetics, largely attributed to pharmacogenomic factors. Objectives: The study aimed to evaluate the impac…
Preview only. Read the full abstract at the source